Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Breast Cancer

  Free Subscription

Articles published in BMJ

Retrieve available abstracts of 25 articles:
HTML format

Single Articles

    July 2022
  1. MENKES DB, Hoeh NR
    Doctor-patient relationship is essential to curtail overdiagnosis.
    BMJ. 2022;378:o1750.

  2. WISE J
    NICE approves two more treatment options for advanced breast cancer.
    BMJ. 2022;378:o1751.

    June 2022
    NICE recommends new targeted treatment for early breast cancer.
    BMJ. 2022;377:o1491.

    A full time job: a year with early-stage breast cancer.
    BMJ. 2022;377:o1421.

    May 2022
  5. WISE J
    NICE allows immunotherapy treatment for small group of patients with advanced triple negative breast cancer.
    BMJ. 2022;377:o1311.

  6. WISE J
    Breast cancer: NICE recommends innovative magnetic technology for locating sentinel lymph nodes.
    BMJ. 2022;377:o1226.

    March 2022
  7. SAUL H, Gursul D, Cassidy S, Vinogradova Y, et al
    Risk of breast cancer with HRT depends on therapy type and duration.
    BMJ. 2022;376:o485.
    PubMed     Abstract available

    Breast cancer is overdiagnosed in one in six or seven cases, finds large US study.
    BMJ. 2022;376:o581.

    January 2022
  9. BARTHOLOMEW T, Colleoni M, Schmidt H
    Financial incentives for breast cancer screening undermine informed choice.
    BMJ. 2022;376:e065726.

    December 2021
  10. CONFORTI F, Pala L, Sala I, Oriecuia C, et al
    Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis.
    BMJ. 2021;375:e066381.
    PubMed     Abstract available

  11. KRZYZANOWSKA MK, Julian JA, Gu CS, Powis M, et al
    Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial.
    BMJ. 2021;375:e066588.
    PubMed     Abstract available

    November 2021
  12. BRUCE J, Mazuquin B, Canaway A, Hossain A, et al
    Exercise versus usual care after non-reconstructive breast cancer surgery (UK PROSPER): multicentre randomised controlled trial and economic evaluation.
    BMJ. 2021;375:e066542.
    PubMed     Abstract available

    September 2021
  13. FREEMAN K, Geppert J, Stinton C, Todkill D, et al
    Use of artificial intelligence for image analysis in breast cancer screening programmes: systematic review of test accuracy.
    BMJ. 2021;374:n1872.
    PubMed     Abstract available

    July 2021
  14. MAGUIRE R, McCann L, Kotronoulas G, Kearney N, et al
    Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART).
    BMJ. 2021;374:n1647.
    PubMed     Abstract available

    April 2021
  15. ABUDHAISE H, Dani M, Devalia H
    Unilateral nipple rash in a man.
    BMJ. 2021;373:n750.

    March 2021

  16. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai.
    BMJ. 2021;372:n738.

    February 2021
  17. MITTRA I, Mishra GA, Dikshit RP, Gupta S, et al
    Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai.
    BMJ. 2021;372:n256.
    PubMed     Abstract available

  18. MN W, L J, Jw H, Ks R, et al
    Use of SNP chips to detect rare pathogenic variants: retrospective, population based diagnostic evaluation.
    BMJ. 2021;372:n214.
    PubMed     Abstract available

    December 2020
  19. DODWELL D, Jauhari Y, Gathani T, Cromwell D, et al
    Treatment variation in early breast cancer in the UK.
    BMJ. 2020;371:m4237.

    November 2020
  20. CHIN YR, Warner R
    Diffuse bruising on left breast.
    BMJ. 2020;371:m4179.

  21. KLEE G, Langan EA
    Just an odd rash?
    BMJ. 2020;371:m4032.

    October 2020
  22. VINOGRADOVA Y, Coupland C, Hippisley-Cox J
    Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases.
    BMJ. 2020;371:m3873.
    PubMed     Abstract available

    Pause in breast cancer screening is opportunity to re-evaluate programme, says critic.
    BMJ. 2020;371:m3810.

    September 2020
    Blatant disregard to proper consent continues in screening programmes.
    BMJ. 2020;370:m3592.

  25. ZHANG Y, Birmann BM, Han J, Giovannucci EL, et al
    Personal use of permanent hair dyes and cancer risk and mortality in US women: prospective cohort study.
    BMJ. 2020;370:m2942.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.